Maya Guglin, MD, PhD


Dr. Guglin was previously an Associate Professor of Medicine and Director of Heart Failure at University of South Florida. She also ran the adult congenital heart disease program (together with Dr. Dadlani) and cardiomyopathy clinic, seeing patients with genetic and familial cardiomyopathy, peripartum cardiomyopathy, cardiac amyloidosis, cardiac sarcoidosis, chemotherapy-induced cardiomyopathy, and right ventricular failure.

A native of Russia, she graduated from Volgograd Medical School and worked as a Cardiology attending in the CCU for several years before coming to the US. Her American training took place at Case Western Reserve University (residency) and UMDNJ (fellowship). As a USF faculty she practiced not only in University clinics but also at Tampa General Hospital and Moffitt Cancer Institute.

Dr. Guglin’s clinical and research interests include heart failure, chemotherapy-induced cardiomyopathy, adult congenital heart diseases, pulmonary hypertension, unusual cardiomyopathies, echocardiography, cardiac transplantation and left ventricular assist devices. Dr. Guglin authored and co-authored about 50 articles in peer reviewed journals. She regularly presents at scientific sessions of the American Heart Association, American College of Cardiology, and Heart Failure Society of America. She is a member of the ACC Heart Failure and Transplant Committee.

Navin Rajagopalan, MD


Dr. Rajagopalan is the Director of Heart Failure and the Medical Director of Cardiac Transplantation at the University of Kentucky. He obtained his medical degree from The Ohio State University and completed his internal medicine training at the Mayo Clinic in Rochester, Minnesota. He completed both a cardiology fellowship and a heart failure/transplant fellowship at the University of Pittsburgh. He is board certified in cardiovascular diseases and advanced heart failure and cardiac transplantation.

Maher Baz, MD


Maher Baz, MD, received his MD from American University of Beirut. He then trained in medicine and pulmonology at Duke University. After graduating, he was hired by the University of Florida in 1995 and served as medical director of their lung transplant program until summer 2013. He joins UK as medical director of transplant pulmonology from Indiana University after a total of 23 years in the lung transplant field.

Malay Shah, MD


Malay Shah, MD, is the Surgical Director of the Liver Transplant Program at the University of Kentucky. He is originally from the Cincinnati area and attended college at the University of Cincinnati. While in Cincinnati, he worked closely with researchers who were involved in transplant and immunosuppression outcomes research. At this time, he developed a keen interest in transplantation. He subsequently attended medical school in Toledo, Ohio at the Medical College of Ohio, completed general surgery residency at the Medical College of Georgia, and completed his fellowship in Abdominal Transplant Surgery at the University of Alabama at Birmingham.

Dr. Shah completed a transplant surgery fellowship at the University of Alabama at Birmingham. When he finished his training, he eagerly jumped at the opportunity to come to the University of Kentucky and return to the area he considers home.

Dr. Shah's interests include liver, kidney and pancreas transplantation. He also has significant interests in hepatobiliary surgery, liver tumors cholangiocarcinoma and vascular access for patients with renal failure. He has a keen interest in socioeconomic and healthcare disparities and their impact on organ donation. He actively participates in national organizations such as the United Network of Organ Sharing as well as multiple transplant societies.

Tom Waid, MS, MD


Thomas Waid, MD, MS, is a professor of internal medicine specializing in nephrology at the University of Kentucky College of Medicine. He graduated with a Bachelor of Science degree in pharmacy from the University of Cincinnati in 1972. He received his master’s degree and medical degree from the University of Kentucky in 1980.

Since that time, Dr. Waid has served in numerous leadership positions, including medical director of the kidney transplantation program from 1985 to present; medical director of the pancreas transplant program 1995 to present; medical director of the heart transplant program from 1992 to 2007; medical director of the lung transplant program from 1992 to 2007; and director of dialysis until 2008.

Dr. Waid co-founded the continuous renal replacement therapy program with Dr. Marek Kacki when they were both fellows. Dr. Waid also started the Organ Failure and Transplant Network in 2008 and has been its medical director since its inception. He is the past president of Lexington Medical Society and currently serves on the LMS Board of Directors. He currently chairs the LMS commission on advocacy and political activity and also serves on as a Kentucky Medical Association planning committee member.

Jay Zwischenberger, MD


Joseph “Jay” Zwischenberger, M.D. is a cardiothoracic surgeon and clinical-scientist who has earned international recognition for his work in extracorporeal gas exchange in the treatment of severe respiratory failure. His research has focused upon novel therapies and devices for the treatment of diseased and damaged lungs, including work on an artificial lung.

Currently, Dr. Zwischenberger serves as the Johnston-Wright Professor and Chairman of the University of Kentucky College of Medicine Department of Surgery where he leads a department of more than 120 surgeons, scientists, and residents. He is also the Surgeon-in-Chief for UK HealthCare.

After graduating from the University of Kentucky cum laude in 1974 and obtaining a medical degree cum laude from UK College of Medicine in 1977, Dr. Zwischenberger completed his general surgery residency and cardiothoracic surgery residency at the University of Michigan. He also completed a cardiac surgery fellowship at the National Institutes of Health and received extracorporeal membrane oxygenation and critical care training from the University of Michigan, where he was mentored by Doctor Robert Bartlett. Prior to returning to the University of Kentucky, Dr. Zwischenberger was a faculty member at the University of Texas Medical Branch (UTMB) for almost 20 years, where he served as Professor of Surgery, Medicine, and Radiology.

Dr. Zwischenberger sees one of his roles at UK as being a catalyst in the development of cross-fertilization – that is, surgeons teaming with physiologists, bioengineers, neonatologists, radiologists and others that focus on translational science, to develop new approaches and then carry them forward from bench to bedside.

Dr. Zwischenberger has authored or co-authored over 350 peer-reviewed publications, 75 book chapters and six books. He holds 2 patents, has several patents pending, serves on several NIH study sections, and is editor emeritus of the American Society for Artificial Internal Organs Journal.

Zwisch, as he is known to many, says that his interest in surgery began when he rebuilt his first Model A Ford as a teenager, a passion he still enjoys today as an antique car enthusiast. He considers himself an amateur musician and is never far from his harmonica, often filling the halls of UK with his brand of bluegrass and blues, much to the delight of the patients and staff. Zwisch also enjoys his “hobby” farm where he raises chickens, has an organic vegetable garden, and is learning the art of beekeeping.

Jon Berger


Dr. Berger is an Assistant Professor in the Department of Surgery, Division of Abdominal Transplant at the University of Kentucky. He graduated medical school from the University of Chicago in 2005 and completed his general surgery training in 2013 at Johns Hopkins Hospital in Baltimore, MD. During his residency, he completed the Graduate Training Program in Clinical Investigation at the Johns Hopkins School of Public Health, where he earned a Masters in Health Sciences degree in 2011. He has been certified by the American Board of Surgery. In 2015 he completed a two year fellowship at the University Michigan, where he earned the American Society of Transplant Surgeons certificates for liver and kidney transplant as well as hepatobiliary surgery. In August 2015, Dr. Berger joined the abdominal transplant and multidisciplinary hepatobiliary tumor teams at UK. His clinical interests include living and deceased donor abdominal transplantation, benign and malignant diseases of the liver and biliary tract, and dialysis access.

Dr. Berger has formal training in biostatistics and epidemiology. His academic interests include investigating the effects of aging and obesity in both the donor and recipient pool of liver and kidney transplant candidates. He is particularly interested in how comorbid conditions and socioeconomic disparities affect access to transplantation and referral patterns.

Michael Daily, MD


Michael Daily is the Surgical Director of the Adult and Pediatric Kidney Transplant Program and the Pancreas Transplant Program at the University of Kentucky. He graduated college from Carroll College in Montana and completed graduate school at California State University, Northridge. While working for a pharmaceutical company in New Mexico, he applied to medical school at the University of Utah. It was then that he discovered an interest in surgery, which led to transplant surgery. His Transplant Surgery Fellowship was at the Thomas E. Starzl Transplantation Institute in Pittsburgh. From there, he took a position on the faculty at the University of California, Davis, before joining UK in 2009. His interests include adult and pediatric kidney transplant, pancreas transplant, live donor kidney transplant, dialysis access. including peritoneal dialysis catheters, liver masses, and resections.